Safety Alerts and Recalls

Unapproved eye products pose a significant risk of harm.

Use of the affected product can potentially lead to underdosing or overdosing due to non-uniform distribution of cyclosporine.

These products were distributed nationwide.

These products are used as lubricant eye drops and are being recalled out of an abundance of caution due to a risk for bacterial and fungal contamination.

According to the FDA, there are no legally marketed ophthalmic products that contain MSM as an active ingredient.

Syfovre is indicated for the treatment of geographic atrophy secondary to age-related macular degeneration.

The safety alert includes tests intended to detect pregnancy.

The recalled products were distributed nationwide to wholesalers, drug chains, mail order pharmacies and supermarkets between June 2022 to May 2023.

Tirzepatide is a once-weekly, dual glucose-dependent insulinotropic polypeptide and glucagon-like peptide-1 receptor agonist.

This recall has been classified as a Class I recall.